logo
Structure-based design of hepatitis C virus inhibitors
Dynamics of hepatitis C virus quasispecies turnover during interferon-α treatment
A prospective study of blood alpha-fetoprotein messenger RNA as a predictor of hepatocellular carcinoma in patients with cirrhosis
Hepatitis C virus proteins do not directly trigger fibrogenic events in cultured human liver myofibroblasts
Effects of hepatitis A vaccination on atherogenesis in a murine model
Comparative study of the efficacy of an induction dose of interferon-α2b with ribavirin compared with standard combined treatment in naive patients with chronic hepatitis C
A serological study of intrafamilial spread from patients with sporadic hepatitis E virus infection
Changing relative roles of hepatitis B and C viruses in the aetiology of hepatocellular carcinoma in Greece. Epidemiological and clinical observations
Occult hepatitis C virus infection in type II mixed cryoglobulinaemia
Daily induction combination treatment with alpha 2b interferon and ribavirin or standard combination treatment in naive chronic hepatitis C patients. A multicentre randomized controlled trial*
Vogt-Koyanagi-Harada disease associated with interferon alpha-2b/ribavirin combination therapy